Cleerly (Series C extension)

Funding Details
Awarder
Inbox
Date Award
December 04, 2024
Vertical
Biotech and Health
Funding URL
View Funding Page
Funding Amount:
$106,000,000

Company Info
Founding Year
2017
Traction
Cleerly has achieved over 100% compounded annual growth over the last four years and has had its software commercially available for that duration.
Founders
James Min
Company Description
Cleerly is a cardiovascular imaging startup that analyzes CT scans of the heart using AI software to identify early-stage coronary artery disease, aiming to improve early detection of heart conditions.
Market
Cardiovascular Health
Location
United States
Coinvestors
Battery Ventures

Links